Join the club for FREE to access the whole archive and other member benefits.

BioNTech

Company developing patient-specific immunotherapies for cancer.

At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized.

To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing in parallel our own state-of-the-art manufacturing processes to complement our drug development platforms.

Visit website: https://biontech.de/

 biontech-se

 BioNTech_Group

Details last updated 10-Jun-2020

People at BioNTech

Ozlem Tureci

Co-Founder and Chief Medical Officer of BioNTech

Ugur Sahin

Professor Medicine at University of Mainz and Co-Founder and CEO of BioNTech.

BioNTech News

AI revolutionizes research: A new era for scientific discovery

Singularity Hub - 07-Oct-2024

Balancing productivity gains with the risk of low-quality research

Read more...

Vaccine trial in the UK begins a new era in lung cancer treatment

BBC - 23-Aug-2024

New mRNA-based vaccine takes center stage in promising lung cancer care

Read more...

BioNTech begins human trials for mRNA therapy targeting colon cancer and melanoma

Lifespan.io (LEAF) - 10-Sep-2021

mRNA cocktail treatment shows anti-tumor effect without toxic side effects in mice

Read more...

Cancer vaccines based on mRNA technology will be available soon

Sky News - 19-Mar-2021

Science behind developing Covid-19 vaccines could bring us cancer shots too

Read more...

BioNTech's vaccine prevents multiple sclerosis in rodents

FierceBiotech - 07-Jan-2021

Developed through a novel mRNA technology used in vaccine for COVID-19

Read more...

Personalized cancer vaccines vanquish melanoma

Scientific American - 06-Jul-2017

Six melanoma patients given an experimental, custom-made, neoantigen vaccine. None of their tumo...

Read more...

Could mRNA Overtake all other Biologicals in Medicine?

Labiotech - 05-Jan-2016

What if we could send the body an instruction to produce its own drug? RNA strand seems easier t...

Read more...
Topics mentioned on this page:
Immunotherapy, Cancer